JP2025122021A5 - - Google Patents
Info
- Publication number
- JP2025122021A5 JP2025122021A5 JP2025080466A JP2025080466A JP2025122021A5 JP 2025122021 A5 JP2025122021 A5 JP 2025122021A5 JP 2025080466 A JP2025080466 A JP 2025080466A JP 2025080466 A JP2025080466 A JP 2025080466A JP 2025122021 A5 JP2025122021 A5 JP 2025122021A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- inflammatory
- pharmaceutical composition
- inflammatory peptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019901968 | 2019-06-06 | ||
| AU2019901968A AU2019901968A0 (en) | 2019-06-06 | Anti-inflammatory agents | |
| JP2021571995A JP2022536289A (ja) | 2019-06-06 | 2020-06-05 | 抗炎症剤 |
| PCT/AU2020/050572 WO2020243787A1 (en) | 2019-06-06 | 2020-06-05 | Anti-inflammatory agents |
| JP2023093379A JP2023126760A (ja) | 2019-06-06 | 2023-06-06 | 抗炎症剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023093379A Division JP2023126760A (ja) | 2019-06-06 | 2023-06-06 | 抗炎症剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025122021A JP2025122021A (ja) | 2025-08-20 |
| JP2025122021A5 true JP2025122021A5 (enExample) | 2025-11-14 |
Family
ID=73652576
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571995A Pending JP2022536289A (ja) | 2019-06-06 | 2020-06-05 | 抗炎症剤 |
| JP2023093379A Pending JP2023126760A (ja) | 2019-06-06 | 2023-06-06 | 抗炎症剤 |
| JP2025080466A Pending JP2025122021A (ja) | 2019-06-06 | 2025-05-13 | 抗炎症剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571995A Pending JP2022536289A (ja) | 2019-06-06 | 2020-06-05 | 抗炎症剤 |
| JP2023093379A Pending JP2023126760A (ja) | 2019-06-06 | 2023-06-06 | 抗炎症剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230002446A1 (enExample) |
| EP (1) | EP3980440A4 (enExample) |
| JP (3) | JP2022536289A (enExample) |
| CN (1) | CN114555624A (enExample) |
| AU (2) | AU2020289132A1 (enExample) |
| WO (1) | WO2020243787A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114409759B (zh) * | 2022-01-28 | 2022-07-12 | 长春普思康医疗科技有限公司 | 一种具有抑菌功能的rp23蛋白 |
| CN118453838B (zh) * | 2024-07-12 | 2024-10-01 | 昆明医科大学第一附属医院(云南省皮肤病医院) | 倭蛙皮肤抗氧化肽antioxidin-NV在制备皮肤抗炎、抗过敏的药物中的应用 |
| CN119219737B (zh) * | 2024-11-15 | 2025-09-16 | 华南农业大学 | 一种贝壳珍珠层来源抗炎活性肽及其在制备皮肤修复产品中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL158140A0 (en) * | 2003-09-25 | 2004-03-28 | Hadasit Med Res Service | Multiepitope polypeptides for cancer immunotherapy |
| US8298522B1 (en) * | 2005-05-13 | 2012-10-30 | Kwang Chul Kim | Methods of modulating MUC1 expression to inhibit inflammation |
| US8129345B2 (en) * | 2006-07-20 | 2012-03-06 | Dana-Farber Cancer Institute, Inc. | MUC1-IκB kinase complexes and their activities |
| CA2665816C (en) * | 2006-09-21 | 2016-07-12 | Vaxil Biotherapeutics Ltd. | Antigen specific multi epitope vaccines |
| US8809002B2 (en) * | 2008-07-10 | 2014-08-19 | Dana-Farber Cancer Institute, Inc. | MUC1, caspase-8, and DED-containing proteins |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| JP5702371B2 (ja) * | 2009-05-27 | 2015-04-15 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | Ｍｕｃ１のアンタゴニストを使用した、炎症の阻害 |
| WO2011100688A1 (en) * | 2010-02-12 | 2011-08-18 | Dana-Farber Cancer Institute, Inc. | Improved antagonists of muc1 |
| WO2016172219A1 (en) * | 2015-04-24 | 2016-10-27 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for inhibition of toll-like receptors (tlrs)-mediated inflammation |
-
2020
- 2020-06-05 EP EP20818083.6A patent/EP3980440A4/en active Pending
- 2020-06-05 JP JP2021571995A patent/JP2022536289A/ja active Pending
- 2020-06-05 WO PCT/AU2020/050572 patent/WO2020243787A1/en not_active Ceased
- 2020-06-05 US US17/616,809 patent/US20230002446A1/en active Pending
- 2020-06-05 AU AU2020289132A patent/AU2020289132A1/en not_active Abandoned
- 2020-06-05 CN CN202080052404.9A patent/CN114555624A/zh active Pending
-
2023
- 2023-06-06 JP JP2023093379A patent/JP2023126760A/ja active Pending
- 2023-09-20 AU AU2023233094A patent/AU2023233094B2/en active Active
-
2025
- 2025-05-13 JP JP2025080466A patent/JP2025122021A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025122021A5 (enExample) | ||
| EP2686431B1 (en) | Antagonists of the interleukin- 1 receptor | |
| US20230158100A1 (en) | Treatment of panx1 associates diseases | |
| CN1917898B (zh) | 用于治疗间质肺部感染的血管活性肠肽的生物活性物质 | |
| US11129875B2 (en) | Osteoarthritis treatment with chemokine-loaded alginate microparticles | |
| US7589062B2 (en) | Two synthetic peptides for treatment and prevention of cancers | |
| JPWO2020055812A5 (enExample) | ||
| CN113660933A (zh) | 透明质酸复合物及其用途 | |
| CN113501862B (zh) | 一种多肽及其在制备免疫调节药物中的应用 | |
| NZ541493A (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| JP7242059B2 (ja) | シェーグレン症候群の治療用ペプチド | |
| CN116212040B (zh) | 一种作为Treg靶向调节剂的PEG修饰IL-2的组合物及其制备方法和用途 | |
| JP2016519110A5 (enExample) | ||
| CN121021828A (zh) | 新型树枝状大分子衍生物的合成及应用 | |
| NZ615710B2 (en) | Antagonists of the interleukin- 1 receptor | |
| Mattos et al. | Interleukin-10 steers the hepatic stellate cell-macrophage axis during liver fibrogenesis | |
| JPH08333274A (ja) | 悪性腫瘍治療用キット | |
| JP2007191436A (ja) | Ｉｌ−２１を含有する医療用組成物 |